| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel
The NK cell cytotoxic activity is regulated by both inhibitory and activating NK receptors. Thus, changes in the expression levels and in the affinity or avidity of those receptors will have a major effect on the killing of target cells. In this study, we demonstrate that the binding of NK-inhibitory receptors is enhanced after influenza virus infection. Surprisingly, however, no change in the level of class I MHC protein expression was observed on the surface of the infected cells. The increased binding was general, because it was observed in both the killer cell Ig-like receptor 2 domain long tail 1 and leukocyte Ig-like receptor-1. The increased binding was functional, was not dependent on the interaction with viral hemagglutinin-neuraminidase, was not dependent on the glycosylation site, and was not abolished after mutating the transmembrane or cytosolic portions of the class I MHC proteins. Confocal microscopy experiments showed increased binding of NK receptor-coated beads to infected cells expressing the appropriate class I MHC proteins. In addition, specific cell-free bead aggregates covered with class I MHC proteins were observed only in infected cells. We therefore suggest that the influenza virus use a novel mechanism for the inhibition of NK cell activity. This mechanism probably involves the generation of class I MHC complexes in infected cells that cause increased recognition of NK receptors.
This article has been cited by other articles:
|
|
 |
|
  N. Stanietsky, H. Simic, J. Arapovic, A. Toporik, O. Levy, A. Novik, Z. Levine, M. Beiman, L. Dassa, H. Achdout, et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity PNAS, October 20, 2009; 106(42): 17858 - 17863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Stern-Ginossar, N. Saleh, M. D. Goldberg, M. Prichard, D. G. Wolf, and O. Mandelboim Analysis of Human Cytomegalovirus-Encoded MicroRNA Activity during Infection J. Virol., October 15, 2009; 83(20): 10684 - 10693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Achdout, I. Manaster, and O. Mandelboim Influenza Virus Infection Augments NK Cell Inhibition through Reorganization of Major Histocompatibility Complex Class I Proteins J. Virol., August 15, 2008; 82(16): 8030 - 8037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Hershkovitz, A. Zilka, A. Bar-Ilan, S. Abutbul, A. Davidson, M. Mazzon, B. M. Kummerer, A. Monsoengo, M. Jacobs, and A. Porgador Dengue Virus Replicon Expressing the Nonstructural Proteins Suffices To Enhance Membrane Expression of HLA Class I and Inhibit Lysis by Human NK Cells J. Virol., August 1, 2008; 82(15): 7666 - 7676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Hershkovitz, M. Jarahian, A. Zilka, A. Bar-Ilan, G. Landau, S. Jivov, Y. Tekoah, R. Glicklis, J. T. Gallagher, S. C. Hoffmann, et al. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool Glycobiology, January 1, 2008; 18(1): 28 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Owen, E. Yamada, C. I. Thompson, L. J. Phillipson, C. Thompson, E. Taylor, M. Zambon, H. M. I. Osborn, W. S. Barclay, and P. Borrow Alterations in Receptor Binding Properties of Recent Human Influenza H3N2 Viruses Are Associated with Reduced Natural Killer Cell Lysis of Infected Cells J. Virol., October 15, 2007; 81(20): 11170 - 11178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Draghi, A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection J. Immunol., March 1, 2007; 178(5): 2688 - 2698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Betser-Cohen, G. Katz, T. Gonen-Gross, N. Stern, T. I. Arnon, H. Achdout, R. Gazit, and O. Mandelboim Reduced KIR2DL1 Recognition of MHC Class I Molecules Presenting Phosphorylated Peptides. J. Immunol., June 1, 2006; 176(11): 6762 - 6769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Baskin, A. Garcia-Sastre, T. M. Tumpey, H. Bielefeldt-Ohmann, V. S. Carter, E. Nistal-Villan, and M. G. Katze Integration of Clinical Data, Pathology, and cDNA Microarrays in Influenza Virus-Infected Pigtailed Macaques (Macaca nemestrina) J. Virol., October 1, 2004; 78(19): 10420 - 10432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bloushtain, U. Qimron, A. Bar-Ilan, O. Hershkovitz, R. Gazit, E. Fima{dagger}, M. Korc, I. Vlodavsky, N. V. Bovin, and A. Porgador Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp46 J. Immunol., August 15, 2004; 173(4): 2392 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. I. Arnon, H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 Blood, January 15, 2004; 103(2): 664 - 672. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
